TGFB1 and malignant colon neoplasm: In previous studies, DEX proved to suppress cell invasion in bladder cancer [68], inhibited hypoxia-induced EMT in colon cancer cells [69], and reduced TGF-β-induced EMT in non-malignant cells [70].